What is GSK189254 used for?

GSK189254 is being studied as a potential treatment for narcolepsy.

Is GSK189254 an approved medication?

No, GSK189254 is currently in Phase 2 clinical trials and is not yet an approved drug.

What type of drug is GSK189254?

GSK189254 is classified as a small molecule compound.

Can I take GSK189254 for narcolepsy?

While GSK189254 is being researched for narcolepsy, it is still in the testing phase and not available for prescription.

What stage of testing is GSK189254 in?

GSK189254 is currently in Phase 2 of clinical development.

Are there known side effects for GSK189254?

There is currently no detailed information available regarding the side effects of GSK189254 in the provided data.

Gsk-189254 | CAS 720690-73-3 | WROHEWWOCPRMIA

Loading compound...

Small molecule research compound

GSK189254 is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential use in treating narcolepsy.

How it worksThe exact biological mechanism of GSK189254 is not detailed in the provided data, but it is categorized as a small molecule targeting multiple biological pathways.

Used for

narcolepsy

Conditions

narcolepsy

Class

Small moleculeSmall molecule research compound

How to take

This drug is currently in clinical development (Phase 2) and is not yet approved for general use by regulatory authorities for any indication.

Talk to your doctor

Questions to ask

·Is GSK189254 part of any narcolepsy clinical trials?
·What are the expected benefits of GSK189254 for narcolepsy?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)